Rapamycin and chronic kidney disease: beyond the inhibition of inflammation
Author:
Publisher
Elsevier BV
Subject
Nephrology
Reference13 articles.
1. Molecular basis of renal fibrosis;Eddy;Pediatr Nephrol,2000
2. Growing roles for the mTOR pathway;Sarbassov;Curr Opin Cell Biol,2005
3. An expanding role for mTOR in cancer;Guertin;Trends Mol Med,2005
4. Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents: three-year results of the RAVEL trial;Fajadet;Circulation,2005
5. Rapamycin: an anti-cancer immunosuppressant?;Law;Crit Rev Oncol Hematol,2005
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Changes in microRNA expression related to ischemia-reperfusion injury in the kidney of the thirteen-lined ground squirrel during torpor;Biochimie;2024-10
2. A combination of the geroprotectors trametinib and rapamycin is more effective than either drug alone;2024-07-25
3. Aging and Diabetic Kidney Disease: Emerging Pathogenetic Mechanisms and Clinical Implications;Current Medicinal Chemistry;2024-02
4. Nicorandil attenuates cisplatin-induced acute kidney injury in rats via activation of PI3K/AKT/mTOR signaling cascade and inhibition of autophagy;International Immunopharmacology;2024-01
5. Rationally Designed Nonapeptides with Great Skin Photoprotective Effect through Producing Type 1 Collagen and Blocking the mTOR Pathway;Journal of Medicinal Chemistry;2023-05-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3